Showing items 1–100
Peptides and combination of peptides for use in immunotherapy against prostate cancer and…
Grant US-11826409-B2
United States of America
Peptides and combination of peptides for use in immunotherapy against prostate cancer and…
Grant US-11786584-B2
United States of America
MUC1-derived peptide, and pharmaceutical composition for treatment or prevention of cancer…
Grant US-11618770-B2
United States of America
Method for activation of helper t cell and composition for use in the method
Grant US-11555814-B2
United States of America
KOC1-derived peptide and vaccine including same
Grant US-11547723-B2
United States of America
WT1 HLA class II-binding peptides and compositions and methods comprising same
Grant US-11548924-B2
United States of America
METHOD OF CHARACTERIZING THE BINDING CHARACTERISTICS BETWEEN A PEPTIDE OF INTEREST AND…
Application WO-2023275023-A1
World Intellectual Property Organisation (WIPO)
METHOD OF CHARACTERIZING THE BINDING CHARACTERISTICS BETWEEN A PEPTIDE OF INTEREST AND…
Application EP-4113120-A1
European Patent Office
METHOD FOR THE ABSOLUTE QUANTIFICATION OF MHC MOLECULES
Application WO-2022184832-A2
World Intellectual Property Organisation (WIPO)
TETANUS TOXOID AND CRM-BASED PEPTIDES AND METHODS OF USE
Application WO-2021102389-A1
World Intellectual Property Organisation (WIPO)
Combinatorial analysis and repair
Grant US-10722562-B2
United States of America
Isolated T cell receptors and methods of use therefor
Grant US-10654908-B2
United States of America
Method for activating helper T cell
Grant US-10654892-B2
United States of America
HLA SINGLE ALLELE LINES
Application WO-2020072700-A1
World Intellectual Property Organisation (WIPO)
PEPTIDE SEQUENCES AND COMPOSITIONS
Application EP-3620463-A1
European Patent Office
KOC1-derived peptide and vaccine including same
Grant US-10576102-B2
United States of America
UBE2T PEPTIDES AND VACCINES CONTAINING THE SAME
Grant EP-2895600-B1
European Patent Office
Molecular vaccines for infectious disease
Grant US-10369204-B2
United States of America
Diagnosis and treatment of autoimmune diseases
Grant US-10364277-B2
United States of America
MHC peptide complexes and uses thereof in infectious diseases
Grant US-10336808-B2
United States of America
Peptide mixture
Grant US-10335473-B2
United States of America
MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1
Grant US-10251912-B2
United States of America
KIF20A epitope peptides for TH1 cells and vaccines containing the same
Grant US-10172926-B2
United States of America
Method for activation of helper T cell and composition for use in the method
Grant US-10139395-B2
United States of America
HLA-DR-binding antigen peptide derived from WT1
Grant US-10124046-B2
United States of America
TOMM34 PEPTIDES AND VACCINES INCLUDING THE SAME
Grant EP-2646546-B1
European Patent Office
PEPTIDE SEQUENCES AND COMPOSITIONS
Application EP-3263589-A2
European Patent Office
CDCA1 EPITOPE PEPTIDES AND VACCINES CONTAINING THE SAME
Grant EP-2303912-B1
European Patent Office
Method for activating helper T cell
Grant US-9833493-B2
United States of America
Multi-epitope peptide-loaded dendritic cell immunotherapy for cancer
Grant US-9783795-B2
United States of America
Method of inducing an immune response by administering WDRPUH epitope peptides
Grant US-9745343-B2
United States of America
HIV peptides and immunogenic compositions
Grant US-9675686-B2
United States of America
Methods and compositions involving immunostimulatory oligodeoxynucleotides
Grant US-9492537-B2
United States of America
NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS
Application EP-3069728-A1
European Patent Office
MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1
Grant US-9447144-B2
United States of America
Tumor antigen based on products of the tumor suppressor gene WT1
Grant US-9403886-B2
United States of America
Vaccinia virus polypeptides
Grant US-9389232-B2
United States of America
Assay method for peptide specific T-cells
Grant US-9360480-B2
United States of America
HLA binding motifs and peptides and their uses
Grant US-9340577-B2
United States of America
Inducing cellular immune responses to Plasmodium falciparum using peptide and nucleic…
Grant US-9266930-B1
United States of America
Immunogenic WT-1 peptides and methods of use thereof
Grant US-9265816-B2
United States of America
Immunomodulatory methods and systems for treatment and/or prevention of hypertension
Grant US-9205141-B2
United States of America
Immunomodulatory methods and systems for treatment and/or prevention of aneurysms
Grant US-9205139-B2
United States of America
Immunogenic peptides and methods of use for treating and preventing cancer
Application US-9206245-B2
United States of America
SEMA5B peptides and vaccines including the same
Grant US-9187556-B2
United States of America
Method of inducing an immune response by administering WDRPUH epitope peptides
Grant US-9115207-B2
United States of America
Novel and powerful MHC-class II peptides derived from survivin
Application EP-2899206-A1
European Patent Office
Peptide Sequences of HIV polypeptides and compositions thereof
Grant US-8992934-B2
United States of America
Immunogens for treatment of neoplastic and infectious disease
Application US-8969012-B2
United States of America
Heteroclitic analogs and related methods
Grant US-8741576-B2
United States of America
Expression vectors encoding epitopes of target-associated antigens and methods for their…
Grant US-8637305-B2
United States of America
Assay method for peptide specific T-cells
Grant US-8617821-B2
United States of America
Peptide vaccines for lung cancers expressing TTK, URLC10 or KOC1 polypeptides
Grant US-8614176-B2
United States of America
KDR peptides and vaccines comprising the same
Grant US-8574585-B2
United States of America
KDR peptides and vaccines comprising the same
Grant US-8574586-B2
United States of America
Compositions for use in the treatment of chronic obstructive pulmonary diseases and asthma
Grant US-8568730-B2
United States of America
Tumor antigen protein SART-3 and tumor antigen peptides thereof
Grant US-8563684-B2
United States of America
WDRPUH epitope peptides and vaccines containing the same
Grant US-8541546-B2
United States of America
TTK peptides and vaccines including the same
Grant US-8530430-B2
United States of America
Immunotherapeutic methods using epitopes of WT-1 and GATA-1
Grant US-8529904-B2
United States of America
Tumour rejection antigens
Grant US-8519109-B2
United States of America
Peptide sequences and compositions
Grant US-8475802-B2
United States of America
Peptide sequences and compositions
Grant US-8444995-B2
United States of America
VACCINE THERAPY FOR CHOROIDAL NEOVASCULARIZATION
Grant EP-2119447-B1
European Patent Office
Peptide epitopes of VEGFR-2/KDR that inhibit angiogenesis
Grant US-8378071-B2
United States of America
Method of inducing a CTL response
Grant US-8372393-B2
United States of America
Epitope sequences
Application EP-2465520-A3
European Patent Office
Expression vectors encoding epitopes of target-associated antigens and methods for their…
Grant US-8252916-B2
United States of America
Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic…
Grant US-8252545-B2
United States of America
Multi-epitope peptide-loaded dendritic cell immunotherapy for cancer
Application EP-2476696-A2
European Patent Office
KDR peptides and vaccines comprising the same
Grant US-8206719-B2
United States of America
Epitope sequences
Application EP-2394655-A3
European Patent Office
IMMUNOTHERAPEUTIC METHOD FOR TREATING PROSTATE CANCER
Application WO-2012026820-A2
World Intellectual Property Organisation (WIPO)
WT1 modified peptide
Application US-8105604-B2
United States of America
Tumor antigen protein SART-3 and tumor antigen peptides thereof
Grant US-8097697-B2
United States of America
Immunogens for treatment of neoplastic and infectious disease
Application US-8088569-B2
United States of America
Epitope sequences
Application EP-2394655-A2
European Patent Office
Peptide sequences and compositions
Application EP-2392587-A1
European Patent Office
Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific…
Application EP-2363406-A2
European Patent Office
SSX-4 peptides presented by HLA class II molecules
Grant US-8008464-B2
United States of America
Method of stimulating an immune response and inhibiting expression of a gene using an…
Grant US-8003619-B2
United States of America
SSX-2 peptides presented by HLA class II molecules
Grant US-7989587-B2
United States of America
Tumor antigen protein SART-3 and tumor antigen peptides thereof
Grant US-7968676-B2
United States of America
Compositions and methods for WT1 specific immunotherapy
Grant US-7915393-B2
United States of America
Compositions and methods for WT1 specific immunotherapy
Grant US-7901693-B2
United States of America
Method of identifying a MHC class I restricted T cell response
Grant US-7892828-B2
United States of America
Cancer antigens based on products of the tumor suppressor gene WT1
Application EP-2280031-A1
European Patent Office
SSX-4 peptides presented by HLA class II molecules
Grant US-7858743-B2
United States of America
Cancer immunotherapy and diagnosis using universal tumor associated antigens, including…
Grant US-7851591-B1
United States of America
Multi-epitope peptide-loaded dendritic cell immunotherapy for cancer
Grant US-7846446-B2
United States of America
Peptide vaccines for lung cancers expressing TTK, URLC10 or KOC1 polypeptides
Grant US-7847060-B2
United States of America
Tumor antigen based on products of the tumor suppressor gene WT1
Grant US-7807792-B2
United States of America
Methods for therapeutic vaccination
Grant US-7807441-B2
United States of America
Antigenic peptides derived from telomerase
Grant US-7794723-B2
United States of America
Compositions and methods for the therapy and diagnosis of lung cancer
Grant US-7749505-B2
United States of America
Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic…
Grant US-7749967-B2
United States of America
Enhanced CTL epitope-containing HIV-1 reverse transcriptase polypeptides
Application US-7731971-B2
United States of America
IMMUNOGENIC WT-1 PEPTIDES AND METHODS OF USE THEREOF
Application US-20100092522-A1
United States of America
KDR peptides and vaccines comprising the same
Grant US-7695720-B2
United States of America
Showing items 1–100